Quick Answer
Envoy Medical, Inc. reported Stockholders Equity of -$12.16 million for fiscal year 2025.
Envoy Medical, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$12.16M | +35.5% |
| 2024 | -$18.84M | -960.9% |
| 2023 | -$1.78M | +95.1% |
| 2022 | -$36.20M | +19.5% |
| 2021 | -$44.96M | -185128.2% |
| 2020 | $24.3K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.66M | +58.7% | +74.3% |
| June 30, 2025 | -$29.86M | -140.8% | -23.3% |
| March 31, 2025 | -$24.22M | -226.2% | -28.6% |
| December 31, 2024 | -$18.84M | -960.9% | -1.6% |
| September 30, 2024 | -$18.54M | -487.4% | -49.5% |
| June 30, 2024 | -$12.40M | +72.5% | -67.0% |
| March 31, 2024 | -$7.43M | +84.4% | -318.2% |
| December 31, 2023 | -$1.78M | +95.1% | -137.1% |
- Envoy Medical, Inc. showed an increase of +35.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, Envoy Medical, Inc.’s stockholders equity has declined by 50135.0% (from $24.3 thousand to -$12.16 million).
- The most recent figure is from Envoy Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: